Answer
Co-administration with ciprofloxacin did not affect ivacaftor exposure, and no ivacaftor dose adjustment is required.
Sources for this answer
- Kalydeco 150 mg film-coated tabletsVertex Pharmaceuticals (Europe) Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 35Document updated
Sources checked